Showing results (1451-1460 of 1,904) with videos related to
Sort By:
Pageof 191
Klinische Monatsblatter Fur Augenheilkunde|March 19, 2009
[Web-based electronic patient record as an instrument for quality assurance within an integrated care concept]A Händel, A G M Jünemann, H-U Prokosch, et al.Journal of the American College of Cardiology|April 3, 2012
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteersAndrew L Frelinger, Ronald D Lee, Darcy J Mulford, et al.Frontiers in Digital Health|March 30, 2022
Sepsis Prediction for the General Ward SettingSean C Yu, Aditi Gupta, Kevin D Betthauser, et al.Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.Journal of Developmental and Behavioral Pediatrics : JDBP|June 15, 2004
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorderLouis S Matza, Anne M Rentz, Kristina Secnik, et al.Journal of the American College of Cardiology|May 16, 2006
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programLars G Olsson, Karl Swedberg, Anique Ducharme, et al.Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.Hospital Pediatrics|June 2, 2021
Pandemic-Related Shifts in New Patients Admitted to Children's HospitalsNicholas A Clark, Jonathan Rodean, Marcos Mestre, et al.Critical Care (London, England)|April 9, 2022
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trialCharles Bruen, Mukhtar Al-Saadi, Edward A Michelson, et al.Pediatric Pulmonology|February 11, 2010
Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and PseudomonasTerry L Noah, Sally S Ivins, Kathleen A Abode, et al.Pageof 191